GEnetic Testing in Elective Single Embryo Transfer (GETSET): A Randomized Clinical Trial
Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
The GETSET trial is a prospective randomized trial designed to evaluate the clinical outcomes of incorporating preimplantation genetic testing for aneuploidies (PGT-A) in elective single embryo transfer in women between 35 and 40 years of age.
Eligibility
Participation Requirements
Sex: Female
Minimum Age: 35
Maximum Age: 40
Healthy Volunteers: f
View:
• Women undergoing IVF of between 35 and 40 years of age at IVF cycle start
• Utilization of Intracytoplasmic Sperm Injection ICSI (recommended) or ---Traditional IVF
• Utilization of ejaculated or testicular sperm
• Utilization of autologous or donor sperm
• All Controlled Ovarian Hyperstimulation (COH) protocols
Locations
United States
Massachusetts
Boston IVF
RECRUITING
Waltham
Contact Information
Primary
Talia Metzgar
talia@genomicprediction.com
(973) 529- 4223
Backup
Kristin Rooney
krooney@bostonivf.com
(781) 434-6500
Time Frame
Start Date: 2023-11-15
Estimated Completion Date: 2026-11-15
Participants
Target number of participants: 240
Treatments
Experimental: Experimental Arm - Transfer of Best Quality, Euploid Blastocyst
Transfer of best quality, PGTA normal (euploid) blastocyst.
No_intervention: Control Arm - Transfer of Untested, Best Quality Blastocyst
Transfer of Untested, Best Quality Blastocyst
Related Therapeutic Areas
Sponsors
Collaborators: Boston IVF
Leads: Genomic Prediction Inc.